A viewpoint paper published on May 22, 2026, in the journal Skin argues that steroid-induced rosacea (SIR) and steroid-induced rosacea-like dermatitis (SIRD) are distinct disorders requiring different clinical management. The authors suggest that these conditions have often been confused, potentially leading to inappropriate treatment.
The authors argue that these conditions have often been confused, potentially leading to inappropriate treatment.
Key Differences Between SIR and SIRD
Steroid-Induced Rosacea-Like Dermatitis (SIRD)
- Described as a curable dermatitis caused by direct steroid damage to the skin barrier.
- Symptoms include intense itching, dryness, and scaling.
- Can appear on atypical areas, such as the upper eyelids.
Steroid-Induced Rosacea (SIR)
- Characterized as true rosacea that is unmasked by steroid use in individuals with a genetic predisposition.
- Causes lifelong episodic flushing and redness confined to the central face.
Clinical Implications of Misdiagnosis
The paper warns that confusion between the two conditions can be clinically harmful.
- In cases of SIRD, early laser therapy may damage skin already compromised by steroid use.
- Treating SIR as a simple skin barrier disruption may ignore its underlying neurovascular cause, potentially leading to repeated flares.
Diagnostic Framework
The authors provide a side-by-side comparison of the two conditions and a step-by-step diagnostic framework designed to guide clinicians in differentiating between SIR and SIRD.